At a Glance
| 1cP-AL-LAD | 25B-NBOH | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | oral | |
| Effects | 51 documented | 60 documented |
Dosage
Only in 1cP-AL-LAD
oral
| Level | Dose |
|---|---|
| Threshold | 20 µg |
| Light | 50–100 µg |
| Common | 100–225 µg |
| Strong | 225–350 µg |
| Heavy | 350 µg |
Duration
Only in 1cP-AL-LAD
oral
Peak
Offset
Afterglow
Onset: 20 min – 1 hrsCome Up: 30 min – 1 hrsPeak: 2.5 hrs – 5 hrsOffset: 2 hrs – 3 hrsAfterglow: 2 hrs – 18 hrs
Total: 7 hrs – 10 hrs
Effects
Safety
Interaction: 1cP-AL-LAD + 25B-NBOH
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
25B-NBOH — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-AL-LAD and 25B-NBOH?
1cP-AL-LAD is classified as a Psychedelic (Lysergamides) while 25B-NBOH is classified as a Psychedelic (Substituted phenethylamines). They share 44 effects in common, with 7 effects unique to 1cP-AL-LAD and 16 unique to 25B-NBOH.
Is it safe to combine 1cP-AL-LAD and 25B-NBOH?
There is no direct interaction data available for combining 1cP-AL-LAD and 25B-NBOH. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-AL-LAD or 25B-NBOH?
1cP-AL-LAD and 25B-NBOH are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.